Tenofovir‐based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|8|675-681

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.8, 2015-08, pp. : 675-681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long‐term entecavir or tenofovir disoproxil fumarate therapy in treatment‐naïve chronic hepatitis B patients in the real‐world setting

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 5, 2015-05 ,pp. : 504-510

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized prospective study showing the non‐inferiority of tenofovir to entecavir in treatment‐naïve chronic hepatitis B patients

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 1, 2018-01 ,pp. : 59-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

A meta‐analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 3, 2015-03 ,pp. : 288-297

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors associated with sustained virological response in 24‐week telaprevir‐based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 387-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive Value of Complete and Partial Early Virological Response on Sustained Virological Response Rates of Genotype-4 Chronic Hepatitis C Patients Treated with PEG-Interferon plus Ribavirin

By  

Intervirology, Vol. 52, Iss. 5, 2009-07 ,pp. : 247-251

Karger

Access to resources Recommend Favorite